Del. Judge Won't Touch Jury's $83M Diagnostics IP Verdict
A Delaware federal judge on Tuesday upheld a jury's 2023 verdict finding that Guardant Health Inc. should pay TwinStrand Biosciences Inc. $83.4 million for willfully infringing diagnostic patents, refusing to overturn...To view the full article, register now.
Already a subscriber? Click here to view full article